Correction to: Role of dopamine agonists in Parkinson's disease therapy

Affiliations

¹ Department of Neurology, Katholische Kliniken Der Ruhrhalbinsel, Essen, Germany. D.Woitalla@kkrh.de.
² Department of Neurology, Universitätsklinikum Hamburg, Hamburg, Germany.
³ Department of Neurology, Klinikum Vest, Recklinghausen, Germany.
⁴ Department of Neurology, Medizinische Hochschule Hannover, Hannover, Germany.
⁵ Department of Neurology Parkinson-Klinik Ortenau, Wolfach, Germany.
⁶ Department of Neurology, Alexianer St. Joseph Krankenhaus, Berlin, Germany.
⁷ Department of Neurology, Asklepios Fachklinikum Stadtroda, Stadtroda, Germany.

Published Erratum

D Woitalla et al. J Neural Transm (Vienna). 2024 Sep.

. 2024 Sep;131(9):1145.

doi: 10.1007/s00702-023-02695-6.

¹ Department of Neurology, Katholische Kliniken Der Ruhrhalbinsel, Essen, Germany. D.Woitalla@kkrh.de.
² Department of Neurology, Universitätsklinikum Hamburg, Hamburg, Germany.
³ Department of Neurology, Klinikum Vest, Recklinghausen, Germany.
⁴ Department of Neurology, Medizinische Hochschule Hannover, Hannover, Germany.
⁵ Department of Neurology Parkinson-Klinik Ortenau, Wolfach, Germany.
⁶ Department of Neurology, Alexianer St. Joseph Krankenhaus, Berlin, Germany.
⁷ Department of Neurology, Asklepios Fachklinikum Stadtroda, Stadtroda, Germany.

No abstract available

Erratum for

Role of dopamine agonists in Parkinson's disease therapy.
Woitalla D, Buhmann C, Hilker-Roggendorf R, Höglinger G, Koschel J, Müller T, Weise D. Woitalla D, et al. J Neural Transm (Vienna). 2023 Jun;130(6):863-873. doi: 10.1007/s00702-023-02647-0. Epub 2023 May 11. J Neural Transm (Vienna). 2023. PMID: 37165120 Review.